Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10030244 Serpina1 iRNA compositions and methods of use thereof

Patent 10030244 was granted and assigned to Alnylam Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071619 SERPINA1 iRNA compositions and methods of use thereof
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+285 characters)
Article

Patent abstract

The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the Serpina1 gene, and methods of using such RNAi agents to inhibit expression of Serpina1 and methods of treating subjects having a Serpina1 associated disease, such as a liver disorder.

Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Alfica Sehgal0
Brian Bettencourt0
Gregory Hinkle0
Kallanthottathil G. Rajeev0
Klaus Charisse0
Martin Maier0
Muthiah Manoharan0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 11406716 Modified RNAi agents
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100302440
Date of Patent
July 24, 2018
0
Patent Application Number
153998200
Date Filed
January 6, 2017
0
Patent Citations Received
‌
US Patent 10668170 Modified RNAi agents
0
‌
US Patent 10995336 Serpina1 iRNA compositions and methods of use thereof
0
‌
US Patent 11406716 Modified RNAi agents
0
Patent Primary Examiner
‌
Amy H Bowman
0
Edits on 10 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11406716 Modified RNAi agents
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10995336 Serpina1 iRNA compositions and methods of use thereof
Edits on 3 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10668170 Modified RNAi agents
Edits on 21 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10030244 Serpina1 iRNA compositions and methods of use thereof

Infobox
Is a
Patent
Patent
Patent applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Current assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10030244
Date of patent
July 24, 2018
Patent application number
15399820
Date Filed
January 6, 2017
Patent primary examiner
‌
Amy H Bowman

Find more entities like US Patent 10030244 Serpina1 iRNA compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo